Trials / Completed
CompletedNCT01637792
Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to explore the impacts of different continuous ambulatory peritoneal dialysis (CAPD) dosage (three 2-Liter exchanges CAPD vs. four 2-Liter exchanges CAPD) on residual kidney function, technique survival, patient survival, and peritonitis in incident Chinese peritoneal dialysis patients.
Detailed description
1. The primary end point for this study was changes in residual kidney function including GFR, daily urine volume (Uvol), and anuria-free survival. GFR and Uvol were evaluated within 1 week before CAPD initiation (the baseline), and then at month 1, 6, 12, 18 and 24. At the same time, body weight, blood pressure, daily net ultrafiltration, dialysis adequacy, peritoneal solute transport rate, and biochemical parameters etc. were assessed. Once an episode of peritonitis or other serious reversible intercurrent illness occurred, all the assessments were delayed one month after being cured. Anuria was termed by daily Uvol permanently less than 100 ml. 2. The secondary end points included technique survival, patient survival and peritonitis. Technique failure was defined as switching to maintenance hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Three 2-liter exchanges daily CAPD | CAPD regimen of three 2-liter daily exchanges |
| OTHER | Four 2-liter exchanges daily CAPD | CAPD regimen of four 2-liter daily exchagnes |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2012-07-11
- Last updated
- 2016-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01637792. Inclusion in this directory is not an endorsement.